Facilitating physiologic self-regeneration: A step beyond islet cell replacement

Pharmaceutical Research

Volumn 23, Issue 2, 2006, Pages 227-242

  Rood, Pleunie P M ^a,b   Bottino, Rita ^a   Balamurugan, A N ^a,b   Fan, Yong ^a   Cooper, David K C ^b   Trucco, Massimo ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Adult stem cells; Autoimmunity; Beta cell regeneration; Islet transplantation; Type 1 diabetes

Indexed keywords

INSULIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR PAX4;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL COUNT; CELL DESTRUCTION; CELL REGENERATION; GENE TRANSFER; HUMAN; IMMUNOTHERAPY; INFUSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; NONHUMAN; PANCREAS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TISSUE REGENERATION;

ANIMALS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS; PRIMATES; REGENERATION; T-LYMPHOCYTES;

EID: 32544457409     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-005-9095-6     Document Type: Review

References (130)

1. J. F. Bach 1994 Insulin-dependent diabetes mellitus as an autoimmune disease Endocr. Rev. 15 516 542
2. D. A. Schaumberg R. J. Glynn A. J. Jenkins T. J. Lyons N. Rifai J. E. Manson P. M. Ridker D. M. Nathan 2005 Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial Circulation 111 2446 2453
3. A. J. Jenkins T. J. Lyons D. Zheng J. D. Otvos D. T. Lackland D. [tmp] McGee W. T. Garvey R. L. Klein DCC/EDIC Research Group 2003 Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia Diabetes Care 26 810 818
4. N. H. White P. A. Cleary W. Dahms D. Goldstein J. Malone W. V. Tamborlane Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group 2001 Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT) J. Pediatr. 139 766 768
5. L. Zhang G. Krentowski A. Albert P. J. Lefebvre 2001 Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control Diabetes Care 24 1275 1279
6. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group 2000 Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy N. Engl. J. Med. 342 381 389
7. Diabetes Research Working Group. Conquering diabetes: a strategic plan for the 21st century. NIH publication no. 99-4398 (1999).
8. R. Bottino A. N. Balamurugan N. Giannoukakis M. Trucco 2002 Islet/pancreas transplantation: challenges for pediatrics Pediatr. Diabetes 3 210 223
9. 2004 OPTN/SRTR Annual Report 1994-2003. 2004 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003. Department of Health and Human Services, Health Resources and Services Administration, Special Programs Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI.
10. R. W. G. Gruessner D. E. R. Sutherland A. C. Gruessner 2004 Mortality assessment for pancreas transplants Am. J. Transp. 4 2018 2026
11. J. M. Venstrom M. A. [tmp] McBride K. I. Rother B. Hirshberg T. J. Orchard D. M. Harlan 2003 Survival after pancreas transplantation in patients with diabetes and preserved kidney function JAMA 290 2817 2824
12. R. P. Robertson C. Davis J. Larsen R. Stratta D. E. R. Sutherland 2000 Pancreas and islet transplantation for patients with diabetes Diabetes Care 23 112 116
13. R. P. Robertson 2002 Islet transplantation as a treatment for diabetes-a work in progress N. Engl. J. Med. 350 694 705
14. R. P. Robertson C. Davis J. Larsen R. Stratta D. E. Sutherland American Diabetes Association 2003 Pancreas transplantation for patients with type 1 diabetes Diabetes Care 26 S120
15. K. I. Rother D. M. Harlan 2004 Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus J. Clin. Invest. 114 877 883
16. P. G. Stock J. A. Bluestone 2004 Beta-cell replacement for type 1 diabetes Annu. Rev. Med. 55 133 156
17. R. Bottino M. Trucco A. N. Balamurugan T. E. Starzl 2002 Pancreas and islet cell transplantation Best Pract. Res., Clin. Gastroenterol. 16 457 474
18. A. M. Shapiro J. R. Lakey E. A. Ryan G. S. Korbutt E. Toth G. L. Warnock N. M. Kneteman R. V. Rajotte 2000 Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N. Engl. J. Med. 343 230 238
19. B. Hirshberg K. I. Rother B. J. Digon J. Lee J. L. Gaglia K. Hines E. J. Read R. Chang B. J. Wood D. M. Harlan 2003 Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression Diabetes Care 26 3288 3295
20. E. A. Ryan J. R. T. Lakey B. W. Paty S. Imes G. S. Korbutt N. M. Kneteman D. Bigam R. V. Rajotte A. M. J. Shapiro 2002 Successful islet transplantation: continued insulin reserve provides long-term glycemic control Diabetes 51 2148 2157
21. E. A. Ryan B. W. Paty P. A. Senior D. Bigam E. Alfadhli N. M. Kneteman J. R. T. Lakey A. M. J. Shapiro 2005 Five-year follow-up after clinical islet transplant Diabetes 54 2060 2069
22. J. J. Casey J. R. Lakey E. A. Ryan B. W. Paty R. Owen K. O'Kelly S. Nanji R. V. Rajotte G. S. Korbutt D. Bigam N. N. Kneteman A. M. Shapiro 2002 Portal venous pressure changes after sequential clinical islet transplantation Transplantation 74 913 915
23. J. F. Markmann M. Rosen E. S. Siegelman M. C. Soulen S. Deng C. F. Barker A. Naji 2003 Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes 52 1591 1594
24. R. J. Owen E. A. Ryan K. O'Kelly J. R. Lakey M. C. [tmp] McCarthy B. W. Paty D. L. Bigam N. M. Kneteman G. S. Korbutt R. V. Rajotte A. M. Shapiro 2003 Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects Radiology 229 165 170
25. C. Ricordi P. E. Lacy E. H. Finke B. J. Olack D. W. Scharp 1988 Automated method for isolation of human pancreatic islets Diabetes 37 413 420
26. A. N. Balamurugan, J. He, F. Guo, D. B. Stolz, S. Bertera, X. Geng, X. Ge, M. Trucco, and R. Bottino. Harmful delayed effects of exogenous isolation enzymes on isolated human islets: relevance to clinical transplantation. Am. J. Transp. In press (2005).
27. A. N. Balamurugan Y. Chang J. J. Fung M. Trucco R. Bottino 2003 Flexible management of enzymatic digestion improves human islet isolation outcome from sub-optimal donor pancreata Am. J. Transp. 9 1135 1142
28. R. Bottino A. N. Balamurugan H. Tse C. Thirunavukkarasu X. Ge J. Profozich M. Milton A. Ziegenfuss M. Trucco J. D. Piganelli 2004 Response of human islets to isolation stress and the effect of antioxidant treatment Diabetes 53 2559 2568
29. R. Bottino A. N. Balamurugan S. Bertera M. Pietropaolo M. Trucco J. D. Piganelli 2002 Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD-mimic compound Diabetes 51 8 2561 2567
30. W. Bennet B. Sundberg C. G. Groth M. D. Brendel D. Brandhorst H. Brandhorst R. G. Bretzel G. Elgue R. Larsson B. Nilsson O. Korsgren 1999 Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal isle transplantation? Diabetes 48 1907 1914
31. M. E. DePaepe B. Keymeulen D. Pipeleers G. Kloppel 1995 Proliferation and hypertrophy of liver cells surrounding islet grafts in diabetic recipient rats Hepatology 21 4 1144 1153
32. C. Ricordi Y. J. Zeng R. Alejandro A. Tzakis R. Venkataramanan J. Fung D. Bereiter D. H. Mintz T. E. Starzl 1991 In vivo effect of FK506 on human pancreatic islets Transplantation 52 519 526
33. K. Tamura T. Fujimura T. Tsutsumi K. Nakamura T. Ogawa C. Atumaru Y. Hirano K. Ohara K. Ohtsuka K. Shimomura 1995 Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell Transplantation 59 1606 1615
34. E. Bell X. Cao J. A. Moibi S. R. Greene R. Young M. Trucco Z. Gao F. M. Matschinsky S. Deng J. F. Markman A. Naji B. A. Wolf 2003 Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets Diabetes 52 2731 2739
35. S. Ringquist M. Trucco 2005 Regenerative medicine for diabetes treatment Discov. Med. 5 142 147
36. B. J. Hering R. Kandaswamy J. D. Ansite P. M. Eckman M. Nakano T. Sawada I. Matsumoto S.-H. Ihm H.-J. Zhang J. Parkey D. W. Hunter D. E. R. Sutherland 2005 Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes JAMA 293 830 835
37. S. Matsumoto T. Okitsu Y. Iwanaga H. Noguchi H. Nagata Y. Yonekawa Y. Yamada K. Fukuda K. Tsukiyama H. Suzuki Y. Kawasaki M. Shimodaira K. Matsuoka T. Shibata Y. Kasai T. Maekawa A. M. J. Shapiro K. Tanaka 2005 Insulin independence after living-donor distal pancreatectomy and islet allotransplantation Lancet 365 1642 1644
38. R. P. Robertson K. J. Lanz D. E. R. Sutherland D. M. Kendall 2001 Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis Diabetes 50 47 50
39. A. Fernandes L. C. King Y. Guz R. Stein C. V. Wright G. Teitelman 1997 Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets Endocrinology 138 1750 1762
40. D. T. Finegood G. C. Weir S. Bonner-Weir 1999 Prior streptozotocin treatment does not inhibit pancreas regeneration after 90% pancreatectomy in rats AJP-Endo 276 822 827
41. L. Li Z. Yi M. Seno I. Kojima 2004 Activin A and betacellulin. Effect on regeneration of pancreatic β-cells in neonatal streptozotocin-treated rats Diabetes 53 608 615
42. J. Movassat B. Portha 1999 Beta-cell growth in the neonatal Goto-Kakisaki rat and regeneration after treatment with streptozotocin at birth Diabetologia 42 1098 1106
43. B. Karges I. Durinovic-Belló E. Heinze B. O. Boehm K.-M. Debatin W. Karges 2004 Complete long-term recovery of β-cell function in autoimmune type 1 diabetes after insulin treatment Diabetes Care 27 1207 1208
44. A. E. Butler J. Janson S. Bonner-Weir R. Ritzel R. A. Rizza P. C. Butler 2003 Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 102 110
45. M. Trucco 2005 Regeneration of the β cell J. Clin. Invest. 115 5 12
46. E. F. Lampeter M. Homberg F. A. Gries H. Kolb K. Quabeck U. W. Schaefer P. Wernet H. Grosse-Wilde J. Bertrams 1993 Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation Lancet 341 1243 1244
47. J. A. Todd J. I. Bell H. O. [tmp] McDevitt 1987 HLA-DQ beta gene contributes to susceptibility and resistance in insulin-dependent diabetes mellitus Nature 329 599 604
48. P. Morel J. Dorman J. Todd H. [tmp] McDevitt M. Trucco 1988 Aspartic acid at position 57 of the HLA DQ-beta chain protects against type I diabetes: a family study Proc. Natl. Acad. Sci. USA 85 8111 8115
49. J. L. Davies Y. Kawaguchi S. T. Bennett J. B. Copeman H. J. Cordell L. E. Pritchard P. W. Reed S. C. L. Gough S. C. Jenkins S. M. Palmer K. M. Balfour B. R. Rowe M. Farrall A. H. Barnett S. C. Bain J. A. Todd 2002 A genome-wide search for human type 1 diabetes susceptibility genes Nature 371 130 136
50. K. L. Lee K. W. Wucherpfennig D. C. Wiley 2001 Structure of a human insulin peptide/HLA-DQ8 complex and susceptibility to type 1 diabetes Nat. Immunol. 2 501 507
51. H. Acha-Orbea H. O. [tmp] McDevitt 1987 The first external domain of the nonobese diabetic mouse class II I-A β chain is unique Proc. Natl. Acad. Sci. 84 2435 2439
52. M. Trucco 1992 To be, or not to be Asp 57, that is the question Diabetes Care 15 705 715
53. H. O. [tmp] McDevitt 2001 Closing in on type 1 diabetes N. Engl. J. Med. 345 1060 1061
54. T. Lund L. O'Reilly P. Hutchings O. Kanagawa E. Simpson R. Gravely P. Chandler D. Dyson J. K. Picard A. Edwards D. Kioussis A. Cooke 1990 Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain Nature 345 727 729
55. J. Böhme B. Shuhbaur O. Kanagawa C. Benoist D. Mathis 1990 MHC-linked protection from diabetes dissociated from clonal deletion of T cells Science 249 293 295
56. N. Parish P. Chandler R. Quartey-Papafio E. Simpson E. Cooke 1993 The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes Eur. J. Immunol. 23 2667 2675
57. D. Hess L. Li M. Martin S. Sakano D. Hill B. Strutt S. Thyssen D. A. Gray M. Bhatia 2003 Bone marrow-derived stem cells initiate pancreatic regeneration Nat. Biotechnol. 21 763 770
58. H. Li C. L. Kaufman S. S. Boggs P. C. Johnson K. D. Patrene S. T. Ildstad 1996 Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice J. Immunol. 156 380 388
59. S. Ikehara H. Ohtsuki R. A. Good H. Asamoto T. Nakamura K. Sekita E. Muso Y. Tochino T. Ida H. Kuzuya H. Imura Y. Hamashima 1985 Prevention of type 1 diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation Proc. Natl. Acad. Sci. USA 82 7743 7747
60. T. D. Zorina V. M. Subbotin S. Bertera A. Alexander A. J. Styche M. Trucco 2002 Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes Cell Transplant 11 113 123
61. T. D. Zorina V. M. Subbotin S. Bertera A. Alexander C. Haluszczak A. Styche B. Gambrell R. Bottino M. Trucco 2003 Recovery of the endogenous beta cell function in autoimmune diabetes Stem Cells 21 377 388
62. C. Tian J. Bagley N. Cretin N. Seth K. W. Wucherpfennig J. Iacomini 2004 Prevention of type 1 diabetes by gene therapy J. Clin. Invest. 114 969 978
63. M. Lipsett D. T. Finegood 2002 β-Cell neogenesis during prolonged hyperglycemia in rats Diabetes 51 1834 1841
64. D. Gu M. S. Lee T. Krahl N. Sarvetnick 1994 Transitional cells in the regenerating pancreas Development 120 1873 1881
65. C. Bernard-Kargar A. Ktorza 2001 Endocrine pancreas plasticity under physiological and pathological conditions Diabetes 50 Suppl. 1 S30 S35
66. T. C. Brelje D. W. Scharp P. E. Lacy L. Ogren F. Talamantes M. Robertson H. G. Friesen R. L. Sorenson 1993 Effect of homologous placental lactogens, prolactins, and growth hormones on islet β-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy Endocrinology 132 879 887
67. L. Rosenberg 1995 In vivo cell transformation: neogenesis of beta cells from pancreatic ductal cells Cell Transplant 4 371 383
68. L. Bouwens 1998 Transdifferentiation versus stem cell hypothesis for the regeneration of islet beta-cells in the pancreas Microsc. Res. Tech. 15 332 336
69. S. Bonner-Weir D. Deery J. L. Leahy G. C. Weir 1989 Compensatory growth of pancreatic beta cells in adult rats after short-term glucose infusion Diabetes 38 49 53
70. M. Arnush D. Gu C. Baugh S. P. Sawyer B. Mroczkowski T. Krahl N. Sarvetnick 1996 Growth factors in the regenerating pancreas of gamma-interferon transgenic mice Lab. Invest. 74 6 985 990
71. P. L. Herrera 2000 Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages Development 127 2317 2322
72. G. Gu J. Dubauskaite D. A. Melton 2002 Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors Development 129 2447 2457
73. R. M. Seaberg S. R. Smukler T. J. Kieffer G. Enikolopov Z. Asghar M. B. Wheeler G. Korbutt D. van der Kooy 2004 Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages Nat. Biotechnol. 22 1115 1124
74. A. Suzuki H. Nakauchi H. Taniguchi 2004 Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting Diabetes 53 2143 2152
75. S. Bonner-Weir E. Toschi A. Inada P. Reitz S. Y. Fonseca T. Aye A. Sharma 2004 The pancreatic ductal epithelium serves as a potential pool of progenitor cells Pediatr. Diabetes 5 16 22
76. S. Bonner-Wier A. Sharma 2002 Pancreatic stem cells J. Pathol. 197 519 526
77. Y. Dor J. Brown O. I. Matinez D. Melton 2004 Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation Nature 429 41 46
78. M. C. Gershengorn A. A. Hardikar C. Wei E. Geras-Raaka B. Marcus-Samuels B. M. Raaka 2004 Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells Science 306 2261 2264
79. M. von Herrath D. Homann 2004 Islet regeneration needed for overcoming autoimmune destruction-considerations on the pathogenesis of type 1 diabetes Pediatr. Diabetes 5 23 28
80. D. E. Sutherland R. Sibley X. Z. Xu A. Michael A. M. Srikanta F. Taub J. Najarian F. C. Goetz 1984 Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes Trans. Assoc. Am. Physicians 97 80 87
81. M. Okabe M. Ikawa K. Kominami T. Nakanishi Y. Nishimune 1997 "Green mice" as a source of ubiquitous green cells FEBS Lett. 407 313 319
82. A. Lechner Y. G. Yang R. A. Blacken L. Wang A. L. Nolan J. F. Habener 2004 No evidence for significant transdifferentiation of bone marrow into pancreatic β-cells in vivo Diabetes 53 616 623
83. A. Biason-Lauber B. Boehm M. Lang-Muritano B. R. Gauthier T. Brun C. B. Wollheim E. J. Schoenle 2005 Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity Diabetologia 48 900 905
84. L. Baeyens S. De Breuck J. Lardon J. K. Mfopou I. Rooman L. Bouwens 2005 In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells Diabetologia 48 1 49 57
85. W. L. Suarez-Pinzon J. R. Lakey S. J. Brand A. Rabinovitch 2005 Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet beta-cells from pancreatic duct cells and an increase in functional beta-cell mass J. Clin. Endocrinol. Metab. 90 6 3401 3409
86. G. D. Block J. Locker W. C. Bowen B. E. Petersen S. Katyal S. C. Strom T. Riley T. A. Howard G. K. Michalopoulos 1996 Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium J. Cell Biol. 132 6 1133 1149
87. A. Garcia-Ocana K. K. Takane M. A. Syed W. M. Philbrick R. C. Vasavada A. F. Stewart 2000 Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia J. Biol. Chem. 275 2 1226 1232
88. J. C. Lopez-Talavera A. Garcia-Ocana I. Sipula K. K. Takane I. Cozar-Castellano A. F. Stewart 2004 Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation Endocrinology 145 2 467 474
89. P. Rao J. Roccisana K. K. Takane R. Bottino A. Zhao M. Trucco A. Garcia-Ocana 2005 Gene transfer of constitutively active akt markedly improves human islet transplant outcomes in diabetic SCID mice Diabetes 54 6 1664 1675
90. Y. Guo Y. Lu D. Houle K. Robertson Z. Tang J. J. Kopchick Y. L. Liu J. L. Liu 2005 Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice Endocrinology 146 6 2602 2609
91. M. George E. Ayuso A. Casellas C. Costa J. C. Devedjian F. Bosch 2002 Beta cell expression of IGF-I leads to recovery from type 1 diabetes J. Clin. Invest. 109 9 1153 1163
92. L. Farilla H. Hui C. Bertolotto E. Kang A. Bulotta U. Di Mario R. Perfetti 2002 Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats Endocrinology 143 4397 4408
93. T. Szkudelski 2001 The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol. Res. 50 536 546
94. M. Elsner M. Tiedge B. Guldbakke S. Lenzen 2002 Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan Diabetologia 45 11 1542 1549
95. E. A. Ryan J. R. Lakey R. V. Rajotte G. S. Korbutt T. Kin S. Imes A. Rabinovitch J. F. Elliott D. Bigam N. M. Kneteman G. L. Warnock I. Larsen A. M. Shapiro 2001 Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol Diabetes 50 4 710 719
96. C. G. Groth O. Korsgren A. Tibell J. Tollemar E. Moller J. Bolinder J. Ostman F. P. Reinholt C. Hellerstrom A. Andersson 1994 Transplantation of porcine fetal pancreas to diabetic patients Lancet 344 1402 1404
97. D. K. Cooper E. Koren R. Oriol 1993 Genetically engineered pigs Lancet 342 8872 682 683
98. C. J. Phelps C. Koike T. D. Vaught J. Boone K. D. Wells S.-H. Chen S. Ball S. M. Specht I. A. Polejaeva J. A. Monahan P. M. Jobst S. M. Sharma A. E. Lamborn A. S. Garst M. Moore A. J. Demetris W. A. Rudert R. Bottino S. Bertera M. Trucco T. E. Starzl Y. Dai D. L. Ayares 2003 Production of α1,3galactosyltransferase deficient pigs Science 299 411 414
99. C. Koike R. P. Friday I. Nakashima P. Luppi J. J. Fung A. S. Rao T. E. Starzl 2000 Isolation of the regulatory regions and genomic organization of the porcine β1,3-galactosyltransferase gene Transplantation 70 1275 1283
100. C. Koike J. J. Fung D. A. Geller R. Kannagi T. Libert P. Luppi I. Nakashima J. Profozich W. A. Rudert S. B. Sharma T. E. Starzl M. Trucco 2002 Molecular basis of evolutionary loss of the α1,3galactosyltransferase gene in higher primates J. Biol. Chem. 277 10114 10120
101. F. J. Dor J. Cheng A. Alt D. K. Cooper H. J. Schuurman 2004 Gal alpha 1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus Xenotransplantation 11 101 106
102. N. Kirchhof S. Shibata M. Wijkstrom D. M. Kulick C. T. Salerno S. M. Clemmings Y. Heremans U. Galili D. E. R. Sutherland A. P. Dalmasso B. J. Hering 2004 Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection Xenotransplantation 11 396 407
103. T. Jie M. Graham M. Wijkstrom T. Aasheim J. Ansite M. Nakano L. Guenther B. Liu K. Moran W. Li N. Kirchhof H. Schuurman B. Hering 2004 Pancreatic islet xenotransplants restore normoglycemia and insulin independence in immunosuppressed non-human primates Transplantation 78 185 abstract O471
104. N. S. Kenyon M. Chatzipetrou M. Masetti A. Ranuncoli M. Oliveira J. L. Wagner A. D. Kirk D. M. Harlan L. C. Burkly C. Ricordi 1999 Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154 Proc. Natl. Acad. Sci. USA 96 8132 8137
105. L. Chatenoud 2003 CD3-specific antibody-induced active tolerance: from bench to bedside Nat. Rev. Immunol. 3 123 132
106. N. Ogawa J. F. List J. F. Habener T. Maki 2004 Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4 Diabetes 53 1700 1705
107. J. Machen J. Harnaha R. Lakomy A. Styche M. Trucco N. Giannoukakis 2004 Antisense oligonucleotides downregulating co-stimulation confer diabetes-preventive properties to NOD dendritic cells J. Immunol. 173 4331 4341
108. M. Trucco N. Giannoukakis 2005 MHC tailored for diabetes cell therapy Gene Ther. 12 553 554
109. M. Pietropaolo M. Trucco 2004 Major histocompatibility locus and other genes that determine the risk of development of insulin-dependent diabetes mellitus D. LeRoith S. Taylor J. M. Olefsky Diabetes Mellitus: A Fundamental and Clinical Text 3 J.B. Lippincott Co. Philadelphia, PA 539 556
110. J. Kaiser 2005 Smart vector restores liver enzyme Science 308 1735 1736
111. R. P. Hollis S. M. Stoll C. R. Sclimenti J. Lin Y. Chen-Tsai M. P. Calos 2003 Phage integrases for the construction and manipulation of transgenic mammals Reprod. Biol. Endocrinol. 1 79 89
112. + T cells and prolonged graft survival in a CTLA4-dependent manner J. Immunol. 164 512 521
113. J. C. Edwards L. Szczepanski J. Szechinski A. Filipowicz-Sosnowska P. Emery D. R. Close R. M. Stevens T. Shaw 2004 Efficacy of B-cell-targeted therapy with Rituximab in patients with rheumatoid arthritis N. Engl. J. Med. 350 25 2572 2581
114. M. R. Canninga-van Dijk H. M. van der Straaten R. Fijnheer C. J. Sanders J. G. van den Tweel L. F. Verdonck 2004 Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease Blood 104 8 2603 2606
115. J. Banchereau R. M. Steinman 1998 Dendritic cells and the control of immunity Nature 392 245 252
116. A. Lanzavecchia F. Sallusto 2001 Regulation of T cell immunity by dendritic cells Cell 106 263 266
117. A. W. Thomson L. Lu 1999 Dendritic cells as regulators of immune reactivity: implications for transplantation Transplantation 68 1 8
118. L. Lu S. Qian T. E. Starzl D. H. Lynch A. W. Thomson 1997 Blocking of the B7-CD28 pathway increases the capacity of FasL (CD95L) dendritic cells to kill alloactivated T cells Adv. Exp. Med. Biol. 417 275 282
119. J. M. [tmp] McBride C. G. Fathman 2002 A complicated relationship: fulfilling the interactive needs of the T lymphocyte and the dendritic cell Pharmacogenomics J. 2 367 376
120. M. J. Clare-Salzler J. Brooks A. Chai K. Van Herle C. Anderson 1992 Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer J. Clin. Invest. 90 741 748
121. M. Feili-Hariri X. Dong S. M. Alber S. C. Watkins R. D. Salter P. A. Morel 1999 Immunotherapy of NOD mice with bone marrow-derived dendritic cells Diabetes 48 2300 2308
122. M. Feili-Hariri D. H. Falkner A. Gambotto G. D. Papworth S. C. Watkins P. D. Robbins P. A. Morel 2003 Dendritic cells transduced to express interleukin-4 prevent diabetes in nonobese diabetic mice with advanced insulitis Hum. Gene Ther. 14 13 23
123. D. J. Weaver Jr. B. Poligone T. Bui U. M. Abdel-Motal A. S. Baldwin Jr. R. Tisch 2001 Dendritic cells from nonobese diabetic mice exhibit a defect in NF-B regulation due to a hyperactive I B kinase J. Immunol. 167 1461 1468
124. B. Poligone D. J. Weaver Jr. P. Sen A. S. Baldwin Jr. R. Tisch 2002 Elevated NF-kappa B activation in nonobese diabetic mouse dendritic cells results in enhanced APC function J. Immunol. 168 188 196
125. P. Sen S. Bhattacharyya M. Wallet C. P. Wong B. Poligone M. Sen A. S. Baldwin Jr. R. Tisch 2003 NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages J. Immunol. 170 1770 1780
126. L. Ma S. Qian X. Liang L. Wang J. E. Woodward N. Giannoukakis P. D. Robbins S. Bertera M. Trucco J. J. Fung L. Lu 2003 Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappa B activity Diabetes 52 1976 1985
127. J. C. Hong B. D. Kahan 2000 Immunosuppressive agents in organ transplantation: past, present, and future Semin. Nephrol. 20 108 125
128. T. Wekerle P. Blaha F. Langer M. Schmid F. Muehlbacher 2002 Tolerance through bone marrow transplantation with costimulation blockade Transpl. Immunol. 9 125 133
129. K. K. Rehman Z. Wang R. Bottino A. N. Balamurugan M. Trucco J. Li X. Xiao P. D. Robbins 2005 Efficient gene delivery to human and rodent islets with double stranded (ds)-AAV2-based vectors Gene Ther. 12 1313 1323
130. Z. Wang, T. Zhu, K. K. Rehman, S. Bertera, J. Zhang, C. Chen, G. Papworth, S. Watkins, M. Trucco, P. D. Robbins, J. Li, and X. Xiao. Efficient and stable pancreatic gene transfer by AAV vectors via differrent routes. Submitted (2005).